Samsung Biologics Co. Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Samsung Biologics recognized as a global leader in water security 2025-12-11 07:30
Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO 2025-11-03 20:00
Samsung Biologics reports third quarter 2025 financial results 2025-10-28 14:50
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™ 2025-10-09 19:00
Samsung Biologics reports second quarter 2025 financial results 2025-07-23 14:54
Samsung Biologics launches drug screening services, Samsung Organoids 2025-06-16 07:30
Samsung Biologics reports first quarter 2025 financial results 2025-04-23 14:46
Samsung Biologics recognized for leadership band in water security 2025-02-12 20:00
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results 2025-01-22 15:06
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference 2025-01-15 09:40
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development 2025-01-09 09:45
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development 2025-01-09 08:57
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery 2024-12-18 13:09
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index 2024-12-17 07:51
Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts 2024-12-03 20:00
Samsung Biologics signs manufacturing deal with European pharmaceutical company 2024-11-20 07:23
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Samsung Biologics reports third quarter 2024 financial results 2024-10-23 14:55
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development 2024-10-14 19:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
1 2 3 4 5 6